RTW Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-821,288
Closed -$17.6M 78
2022
Q4
$17.6M Sell
821,288
-2,803,712
-77% -$59.8M 0.36% 39
2022
Q3
$65M Buy
+3,625,000
New +$47.6M 1.5% 22
2022
Q1
Sell
-6,722,624
Closed -$112M 125
2021
Q4
$112M Hold
6,722,624
1.64% 20
2021
Q3
$109M Hold
6,722,624
1.65% 20
2021
Q2
$42.4M Hold
6,722,624
0.64% 42
2021
Q1
$41.5M Hold
6,722,624
0.65% 44
2020
Q4
$46.5M Buy
6,722,624
+59,185
+0.9% +$379K 0.78% 36
2020
Q3
$37.6M Buy
6,663,439
+66,903
+1% +$319K 0.9% 34
2020
Q2
$33.6M Buy
+6,596,536
New +$27.5M 0.95% 33

Other funds holding ISEE

RTW Investments's ISEE Position: Q1 2023 in Review

RTW Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 821,288 shares — an estimated $17.6M sold.

RTW Investments first reported a position in ISEE in Q2 2020 and held it in 9 quarters. The position peaked at $112M in Q4 2021. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • RTW Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • RTW Investments sold 821,288 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $17.6M.
  • RTW Investments first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • RTW Investments's IVERIC bio, Inc. Common Stock position peaked at $112M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on RTW Investments's 13F filing for Q1 2023, filed 15 May 2023.